Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03838510 · ClinicalTrials.gov registry record · NA
Repeated-dose Behavioral Intervention to Reduce Opioid Overdose
A NA study of Opioid-Related Disorders and Drug Overdose, sponsored by San Francisco Department of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 268
- Enrollment target
- 2
- Study locations
NCT03838510 is a NA study of Opioid-Related Disorders and Drug Overdose that has completed, run by San Francisco Department of Public Health. The registered enrollment target is 268 participants, below the 341-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target (21% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03838510, a NA study of Opioid-Related Disorders and Drug Overdose, has completed, sponsored by San Francisco Department of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 268 participants
- Enrollment target
- 2
- Study locations
Study Summary
REBOOT is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among naloxone recipients with opioid use disorder. It includes an established overdose education curriculum within an Informational-Motivation-Behavior (IMB) model. This study will test the efficacy of REBOOT vs attention-control.
Conditions Studied
Interventions
- BEHAVIORAL REBOOT
Study Locations (2)
California
- San Francisco Department of Public Health - San Francisco
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2019-04-22 |
| Est. Completion | 2023-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03838510
The ClinicalTrials.gov registry entry for NCT03838510 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 341-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target (21% lower). The listed sponsor is San Francisco Department of Public Health, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which REBOOT is the first listed.
NCT03838510 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03838510 about?
NCT03838510 is a clinical study titled "Repeated-dose Behavioral Intervention to Reduce Opioid Overdose". REBOOT is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among naloxone recipients with opioid use disorder. It includes an established overdose education curriculum within an Informational-Motivation-Behavior (IMB) model. This study will test the effi...
What is the current status of trial NCT03838510?
This trial is currently completed. It is a NA study. The enrollment target is 268 participants. The study started on 2019-04-22. Estimated completion is 2023-12-12.
What conditions does trial NCT03838510 study?
This clinical trial studies the following conditions: Opioid-Related Disorders, Drug Overdose.
What interventions are being tested in trial NCT03838510?
The interventions under investigation include: REBOOT (BEHAVIORAL).
Who is sponsoring clinical trial NCT03838510?
This trial is sponsored by San Francisco Department of Public Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03838510 being conducted?
This trial has 2 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
RECRUITING · NA
-
Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment
RECRUITING · NA
-
OUD Smartphone Services
ACTIVE NOT RECRUITING · NA
-
Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing
ACTIVE NOT RECRUITING · NA
-
Healthy Opioid Prescription Engagement
ACTIVE NOT RECRUITING · NA
-
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.